Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System (Q46072379)

19 December 2017

title

Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System (English)

1 reference

19 December 2017

author name string

A H Hautmann

1

1 reference

19 December 2017

D Wolff

2

1 reference

19 December 2017

J Hahn

3

1 reference

19 December 2017

M Edinger

4

1 reference

19 December 2017

N Schirmer

5

1 reference

19 December 2017

J Ammer

6

1 reference

19 December 2017

B Holler

7

1 reference

19 December 2017

K Landfried

8

1 reference

19 December 2017

M G Hautmann

9

1 reference

19 December 2017

N Ahrens

10

1 reference

19 December 2017

P Ugocsai

11

1 reference

19 December 2017

R Andreesen

12

1 reference

19 December 2017

E Holler

13

1 reference

19 December 2017

language of work or name

English

0 references

publication date

27 August 2012

1 reference

19 December 2017

Bone Marrow Transplantation

published in

1 reference

19 December 2017

volume

48

1 reference

19 December 2017

page(s)

439-445

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2012.156

exact match

0 references

cites work

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photopheresis: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Assessing the potential role of photopheresis in hematopoietic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Bone-marrow transplantation (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Bone-marrow transplantation (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photopheresis technical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Quality control for the validation of extracorporeal photopheresis process using the Vilbert-Lourmat UV-A irradiation's system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photochemotherapy for steroid-refractory graft-versus-host disease in low-weight pediatric patients. Immunomodulatory effects and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photopheresis: what is it and when should it be used?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

7 January 2021

Competing risk analysis using R: an easy guide for clinicians

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

7 January 2021

Regression modeling of competing risk using R: an in depth guide for clinicians

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

7 January 2021

Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

7 January 2021

Extracorporeal photochemotherapy for the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

7 January 2021

Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.156

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.156

1 reference

19 December 2017

Dimensions Publication ID

0 references

1 reference

19 December 2017